Classa ordinary shares subject to possible redemption, 0.0001 par value 19,199,029 shares issued and outstanding as of june30, 2026 and december31, 2025 at redemption value of 10.69 and 10.50 per share as of june30, 2026 and december31, 2025, respectively
205,280,770
203,414,191
201,563,532
199,769,089
Common stock value-Common Class A
58
58
58
58
Common stock value-Common Class B
480
480
480
480
Additionalpaid-incapital
0
0
0
0
Accumulated deficit
-7,489,191
-7,227,233
-6,770,695
-6,765,200
Total shareholders' deficit
-7,488,653
-7,226,695
-6,770,157
-6,764,662
Total liabilities, class a ordinary shares subject to possible redemption and shareholders' deficit
206,540,698
204,830,388
203,111,772
201,249,963
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Oaktree Acquisition Corp. III Life Sciences (OACC)
Oaktree Acquisition Corp. III Life Sciences (OACC)